Pulse Biosciences Inc (NAS:PLSE)
$ 14.545 0.835 (6.09%) Market Cap: 803.25 Mil Enterprise Value: 731.15 Mil PE Ratio: 0 PB Ratio: 22.04 GF Score: 41/100

Q4 2019 Pulse Biosciences Inc Earnings Call Transcript

Mar 16, 2020 / 08:30PM GMT
Release Date Price: $5.23 (-9.36%)
Operator

Greetings, welcome to Pulse Biosciences' Reports for the Fourth Quarter and Full Year 2019 Final Results Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to Philip Taylor, Investor Relations. Thank you, you may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflects management's views as of today, March 16, 2020, only, and will include forward-looking statements and opinion statements. These include statements regarding our plans and expectations regarding to regulatory clearance, including the process and expected outcomes, our commercial, operational, scientific, clinical and financial projections, products including the uses and applications of such products and other future events. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot